Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Himisha Beltran, M.D.

Concepts (447)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Himisha Beltran's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Himisha Beltran has written about over time.
Orchiectomy, 8 publications between 2011 and 2020, average publication date May 2014. Adenocarcinoma, 23 publications between 2011 and 2022, average publication date August 2016. Carcinoma, Small Cell, 6 publications between 2011 and 2019, average publication date December 2016. Neuroendocrine Tumors, 27 publications between 2011 and 2023, average publication date August 2017. Drug Resistance, Neoplasm, 19 publications between 2012 and 2021, average publication date September 2017. Prostatic Neoplasms, 110 publications between 2010 and 2024, average publication date July 2018. Gene Expression Regulation, Neoplastic, 34 publications between 2012 and 2022, average publication date August 2018. Receptors, Androgen, 31 publications between 2012 and 2022, average publication date May 2019. Neoplastic Cells, Circulating, 6 publications between 2015 and 2022, average publication date May 2019. Androgen Antagonists, 18 publications between 2011 and 2024, average publication date September 2019. Prostate, 14 publications between 2011 and 2023, average publication date February 2020. Androgen Receptor Antagonists, 8 publications between 2017 and 2022, average publication date June 2020. Carcinoma, Neuroendocrine, 21 publications between 2014 and 2024, average publication date July 2020.

To see the data from this visualization as text, click here.
Beltran's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (447)
Explore
_
Co-Authors (67)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.